EIKN
Eikon Therapeutics, Inc.
7.30$
-1.1%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
Eikon Therapeutics, Inc. (EIKN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -65 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|
| -24 | -55 | -33 | -60 | -42 | -90 | -65 | -256 | |
| 6.2 | 6.5 | 6.3 | 6.3 | 5.1 | 5.1 | 5.0 | 22 | |
| 3.2 | 3.0 | 7.2 | 4.0 | 3.9 | 2.8 | 4.2 | 15 | |
| 33 | 5.5 | 40 | 2.7 | 30 | -14 | 15 | 33 | |
| 40 | 22 | 22 | 2.6 | 0.1 | 0.3 | 0.3 | 3.2 | |
| – | – | – | 28 | 41 | -203 | 46 | -88 | |
| 0.1 | 350 | 0.5 | 0.2 | 1.1 | 349 | 0.0 | 351 | |
| -15 | 82 | -68 | -32 | 0.1 | 56 | -19 | 6.1 | |
| -63 | -77 | -54 | -62 | -42 | -90 | -65 | -259 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.